Vineti and Marker Therapeutics announce strategic partnership to support diverse cell therapy portfolio
22 avr. 2019 10h00 HE
|
Vineti
SAN FRANCISCO and HOUSTON, April 22, 2019 (GLOBE NEWSWIRE) -- Vineti Inc., the leading software platform of record for personalized therapeutics, today announced a new partnership to advance and...
Patient Access to Cell and Gene Therapies Improves with CareMetx and Vineti Alliance
25 mars 2019 09h00 HE
|
Vineti
SAN FRANCISCO, CA and BETHESDA, Md., March 25, 2019 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software platform of record for personalized therapies, and OutcomeRx, a new division of CareMetx,...
Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies
25 févr. 2019 06h15 HE
|
Vineti
SAN FRANCISCO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Vineti Inc, the leading software platform of record for personalized therapeutics, today announced a new partnership to help advance and scale...
Vineti™ to promote greater access to cell and gene therapies, highlight rapid global growth at Phacilitate Leaders World 2019
22 janv. 2019 08h00 HE
|
Vineti
MIAMI, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Vineti Inc., the leading digital platform of record for personalized therapies, today announced that CEO Amy DuRoss will chair two expert panels during...
Vineti Completes $33.5 Million in Series B Financing to Accelerate Patient Access to Cell and Gene Therapies
16 avr. 2018 07h30 HE
|
Vineti
SAN FRANCISCO, April 16, 2018 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software automation and analytics platform for cell and gene therapies, today announced the closing of $33.5 million in...
Vineti expands its platform to support provision of American Red Cross allogeneic apheresis collections for cellular therapy
06 sept. 2017 09h00 HE
|
Vineti
SAN FRANCISCO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software and analytics company for cell and gene therapies, today announced that it will be expanding its technology...